Quantum Sensing for Precision Organ Aging Assessment

Aging Dis. 2026 Feb 26. doi: 10.14336/AD.2025.1500. Online ahead of print.ABSTRACTAging proceeds heterogeneously across organs, making chronological age an inadequate measure of physiological decline. The concept of organ biological age (OBA) offers a refined framework to quantify organ-specific fun

J Jingyi Niu

Understanding the Role of Gut Microbial Enzyme in CMD

Circ Res. 2026 Feb 27;138(5):e326979. doi: 10.1161/CIRCRESAHA.125.326979. Epub 2026 Feb 26.ABSTRACTCardiometabolic diseases (CMDs) refer to a broad spectrum of interconnected disorders, including heart attack, obesity, diabetes, atherosclerosis, and metabolic dysfunction-associated steatohepatitis,

Y Yingying Zhuo

Cumulative average triglyceride glucose-waist height index and incident cardiovascular disease in middle-aged and older adults: A nationwide cohort study from the china health and retirement longitudinal study

PLoS One. 2026 Feb 26;21(2):e0333827. doi: 10.1371/journal.pone.0333827. eCollection 2026.ABSTRACTBACKGROUND: Insulin resistance (IR) is a significant risk factor for cardiovascular disease (CVD), yet practical biomarkers for long-term IR assessment are limited. The triglyceride glucose-waist-to-hei

L Liang Zeng

2025 Clinical practice guidelines of the Mexican Society for HeartCare (SOMECCOR) and the Mexican Society of Cardiology (SMC) on Cardiovascular Rehabilitation and Prevention: therapeutic physical training and heart-healthy lifestyle. Developed by the Task Force for Cardiovascular Rehabilitation and Prevention of the Mexican Society for Heart Care (SOMECCOR) and the Mexican Society of Cardiology (SMC)

Arch Cardiol Mex. 2025 Nov 28;95(Supl 1):1-178. doi: 10.24875/ACM.M25000099.ABSTRACTComprehensive cardiovascular rehabilitation and prevention programs (CVRhP-P) are the cornerstone for improving maximum exercise tolerance, reducing mortality, improving health-related quality of life, and reducing h

H H Ilarraza-Lomelí

Myeloid KIF13B suppresses the STT3A/CTSD/THBS1 Axis to prevent MASH

Hepatology. 2026 Feb 25. doi: 10.1097/HEP.0000000000001726. Online ahead of print.ABSTRACTBACKGROUND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a critical pathological stage that can progress to liver fibrosis and hepatocellular carcinoma, and its development is closel

K Kaikai Lu